CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), a late-stage bio-scientific research company specializing in the early screening and diagnosis of reproductive cancers, today announced the addition of Dr. Stephen Raab to its Medical Advisory Board.
